Renalytix AI PLC Director/PDMR Shareholding (1932L)
21 December 2018 - 4:20AM
UK Regulatory
TIDMRENX
RNS Number : 1932L
Renalytix AI PLC
20 December 2018
Renalytix AI plc
("RenalytixAI" or the "Company")
Director/ PDMR Shareholding
The Company was informed that today, Christopher Mills, a
non-executive director, completed the purchase of 3,168 ordinary
shares of 0.25 pence each ("Ordinary Shares") in the Company at a
price of 112 pence per share.
Following this purchase, Mr Mills is interested in 9,199,568
Ordinary Shares representing 17.09% of the total voting rights in
the Company.
Enquiries:
Renalytix AI plc www.renalytixai.com
James McCullough, CEO Via Walbrook PR or Tel: +1 646
397 3970
---------------------------------------------------
N+1 Singer (Nominated Adviser & Broker) Tel: 020 7496 3000
-----------------------------------------------
Aubrey Powell / James White / George Tzimas
(Corporate Finance)
-----------------------------------------------
Tom Salvesen / Mia Gardner (Corporate Broking)
-----------------------------------------------
Walbrook PR Limited Tel: 020 7933 8780 or renalytix@walbrookpr.com
-----------------------------------------------------
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584
391 303
-------------------------------------------------
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Harwood Capital LLP (Harwood) as
investment manager to North Atlantic
Smaller Companies Investment Trust
plc and Oryx
------------------------------------ ---------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------
a) Position/status Christopher Mills, non-exec director
of the issuer and director of NASCIT
and Oryx International Growth Fund
Ltd
------------------------------------ ---------------------------------------------
b) Initial notification Initial Notification
/Amendment
------------------------------------ ---------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------
a) Name Renalytix AI plc
------------------------------------ ---------------------------------------------
b) LEI 213800NTOH3FK3WER551
------------------------------------ ---------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------------------
a) Description of the Ordinary shares of 0.25 pence each
financial instrument,
type of instrument
Identification code GB00BYWL4Y04
b) Nature of the transaction Share purchase
------------------------------------ ---------------------------------------------
c) Price(s) and volume(s)
------------------------ ----------------
Price(s) Volume(s)
------------------------ ----------------
112.00 pence 3,168
------------------------------------------------------------------ ----------------
d) Aggregated information
- Aggregated volume 3,168
- Price GBP3,548.16
e) Date of the transaction 20 December 2018
------------------------------------ ---------------------------------------------
f) Place of the transaction London Stock Exchange
------------------------------------ ---------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHFKKDDOBDDFBB
(END) Dow Jones Newswires
December 20, 2018 12:20 ET (17:20 GMT)
Renalytix (LSE:RENX)
Historical Stock Chart
From Mar 2024 to May 2024
Renalytix (LSE:RENX)
Historical Stock Chart
From May 2023 to May 2024
